2m 2m 2m 2m 2m 2m 2m
Provectus Biopha (PVCT)
OTC
$0.07+$0.004 (+7.10%)
Price as of Jun 03, 2026- $45.7MMarket Cap
- -14.54%1-Year Change
- BiotechnologyIndustry
Provectus Biopha (PVCT)
$0.07+$0.004 (+7.10%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 58
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.06
$0.07
$0.07
1-Year Range
$0.04
$0.10
$0.07
Latest Close$0.07
Change
+$0.004 (+6.63%)
Volume78,863
Market Cap$45.7M
Shares Outstanding419.5M
P/E (TTM)-14.34
Diluted EPS (TTM)-$0.008
Enterprise Value$54.5M
Information as of 06/03/2026
Company Profile
PROVECTUS BIOPHARMS
$45.7M
Market Cap
-$3.2M
Net Income
Sector: Healthcare
Industry: Biotechnology
PROVECTUS BIOPHARMS
Key Executives
- Dominic Rodrigues
- Edward V. Pershing
- Eric A. Wachter
- Heather Raines
Current Ownership Distribution
- Other379.8M (90.37%)
- Insiders36.3M (8.63%)
- Institutions4.2M (0.99%)
- Mutual Funds0 (0.00%)